A combination treatment approach using two chemotherapy drugs improved treatment response and progression-free survival in patients with advanced pancreatic neuroendocrine tumors, according to a recent clinical trial published in the Journal of Clinical Oncology.
Northwestern Medicine scientists have identified an enzyme which aids tumors in evading the immune system, findings that could provide future directions for tumor treatment, according to a study published in Nature Communications.
Northwestern University scientists have discovered it is possible to isolate a tumor’s attack cells non-invasively from blood, rather than from tumors.
Feinberg medical students came together on March 12 to organize a one-day interactive workshop for community high schoolers with an interest in pursuing a career in medicine.
Northwestern investigators have formed an interdisciplinary group to address the global issue of antimicrobial resistance.
Repeat radiation therapy combined with monoclonal antibody treatment extended progression-free survival in patients with recurrent glioblastoma, according to a recent clinical trial published in the Journal of Clinical Oncology.
Alan Hauser, MD, PhD, vice chair of Microbiology-Immunology, has been named the new director of Feinberg’s Medical Scientist Training Program (MSTP), effective April 15.
Jennifer A. Doudna, PhD, the Li Ka Shing Chancellor’s Chair and professor in the Departments of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley, delivered the inaugural Kimberly Prize in Biochemistry and Molecular Genetics Lecture to Feinberg faculty, staff and students on Tuesday, April 4.
Focus on age, not weight, to capture the greatest number of people in all racial and ethnic groups with prediabetes and diabetes, reports a new Northwestern Medicine study published in the American Journal of Preventive Medicine.
Two therapeutic drugs benefited mice with non-small cell lung cancer, potentially paving the way for clinical trials in humans.
